DEMAX
Price
$26.57
Change
+$0.13 (+0.49%)
Updated
Jun 26 closing price
Net Assets
6.56B
RNWHX
Price
$87.45
Change
+$0.90 (+1.04%)
Updated
Jun 26 closing price
Net Assets
68.99B
Interact to see
Advertisement

DEMAX vs RNWHX

Header iconDEMAX vs RNWHX Comparison
Open Charts DEMAX vs RNWHXBanner chart's image
Macquarie Emerging Markets A
Price$26.57
Change+$0.13 (+0.49%)
VolumeN/A
Net Assets6.56B
American Funds New World R5E
Price$87.45
Change+$0.90 (+1.04%)
VolumeN/A
Net Assets68.99B
DEMAX vs RNWHX Comparison Chart in %
Loading...
View a ticker or compare two or three
VS
DEMAX vs. RNWHX commentary
Jun 27, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is DEMAX is a Hold and RNWHX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
RNWHX has more cash in the bank: 69B vs. DEMAX (6.56B). DEMAX pays higher dividends than RNWHX: DEMAX (1.56) vs RNWHX (1.04). DEMAX was incepted earlier than RNWHX: DEMAX (29 years) vs RNWHX (10 years). DEMAX (1.59) is less costly to investors than RNWHX (0.72). RNWHX is a more actively managed with annual turnover of: 37.00 vs. DEMAX (14.00). RNWHX has a lower initial minimum investment than DEMAX: RNWHX (250) vs DEMAX (1000). DEMAX annual gain was more profitable for investors over the last year : 17.56 vs. RNWHX (11.19). DEMAX return over 5 years is better than : 50.99 vs. RNWHX (35.11).
DEMAXRNWHXDEMAX / RNWHX
Total Expense Ratio1.420.72197%
Annual Report Gross Expense Ratio1.590.72221%
Fund Existence29 years10 years-
Gain YTD31.40515.036209%
Front Load6%N/A-
Min. Initial Investment1000250400%
Min. Initial Investment IRA250N/A-
Net Assets6.56B69B10%
Annual Yield % from dividends1.561.04150%
Returns for 1 year17.5611.19157%
Returns for 3 years48.4235.35137%
Returns for 5 years50.9935.11145%
Returns for 10 years104.88N/A-
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
INTS0.310.01
+2.00%
Intensity Therapeutics
DXC15.200.22
+1.47%
DXC Technology Company
HSII44.060.46
+1.06%
Heidrick & Struggles International
TAP47.24N/A
N/A
Molson Coors Beverage Company
FATE1.10-0.06
-5.17%
Fate Therapeutics